COMPASS THERAPEUTICS INC (CMPX:NASDAQ)
$2.05 -0.03 (-1.4423%)
Analysed COMPASS THERAPEUTICS INC (CMPX:NASDAQ) News Sources
Compass Therapeutics Reports 2026 First Quarter Financial Results and Provides Corporate Update
05-05-2026
yahoo.com
Canaccord Maintains Buy Rating on Compass Therapeutics (CMPX)
05-05-2026
yahoo.com
Compass Therapeutics to Participate in Upcoming May Investor Events
12-05-2026
yahoo.com
Compass Therapeutics (CMPX) Reports Q1 2026 Net Loss of $18.3M
18-05-2026
yahoo.com
Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
Compass Therapeutics to Participate in Upcoming June Investor Events
28-05-2026
yahoo.com
Compass Therapeutics Eyes FDA Path After Tovecimig Trial Win
08-06-2026
marketbeat.com
How Compass Therapeutics (CMPX) Is Moving Tovecimig Toward a Potential Biliary Tract Cancer Filing
17-06-2026
yahoo.com
Here’s Why Citizens Maintains a Buy on Compass Therapeutics (CMPX)
03-07-2026
yahoo.com
Compass Therapeutics Announces Tovecimig Data Accepted for an Oral Presentation at the ESMO Congress 2026
17-07-2026
yahoo.com
What is the current price of COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The current price of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is $2.05.
COMPASS THERAPEUTICS INC (CMPX:NASDAQ) absolute price change since previous trading day?
The absolute price change of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) since the previous trading day is $-0.03.
COMPASS THERAPEUTICS INC (CMPX:NASDAQ) percentage price change since previous trading day?
The percentage price change of COMPASS THERAPEUTICS INC (CMPX:NASDAQ) since the previous trading day is -1.4423%.
What is the most recent average sentiment score for COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The most recent average sentiment score for COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for COMPASS THERAPEUTICS INC (CMPX:NASDAQ)?
The most recent sentiment for COMPASS THERAPEUTICS INC (CMPX:NASDAQ) is .
SEC-8K** Filing Available For COMPASS THERAPEUTICS INC (CMPX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.